XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Income Tax (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
item
Dec. 31, 2021
USD ($)
Income Tax      
Unrecognized tax benefit $ 0   $ 0
Unrecognized income tax benefits impact on effective income tax rate 0   0
Accrual for interest and penalties relating to uncertain income tax positions 0   $ 0
Deferred income tax benefit 600,000    
Number of ownership changes over 50% | item   5  
Federal      
Income Tax      
Net operating loss carryforwards 153,477,285    
NOLs that will expire unutilized   $ 58,182,000  
R&D credits that will expire unutilized   $ 2,935,000  
Federal | Pelican Therapeutics, Inc.      
Income Tax      
Net operating loss carryforwards $ 3,027,284